top of page
  • Benjamí

New collaboration with ONA Therapeutics - Welcome Pol!

We welcome Pol Martín Chulio to the team! He will be pursuing an industrial PhD in collaboration with the thriving biotech company ONA Therapeutics, co-supervised with Dr. Salvador Guardiola. He will be working on developing chemogenetic activation strategies for full-length antibodies.

27 visualizaciones0 comentarios

Entradas Recientes

Ver todo

Chemical & Synthetic Biology
for Biotherapies

Challenging Brain Diseases

ChemSynBio logo 29102023_transparente.png
bottom of page